Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs dexmedetomidine sedation in mechanically ventilated ICU patients
ChiCTR2200056041Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Xinjiang Medical University
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam and dexmedetomidine in respiratory failure and sepsis (2 arms), sponsored by First Affiliated Hospital of Xinjiang Medical University. Primary endpoints: RASS score, Vital signs and 5 more. Started Jun 2022; status: recruiting.
02
Drugs
remimazolamdexmedetomidine
03
Conditions
respiratory failuresepsis
Beyond the preview
Go deeper on ChiCTR2200056041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200056041.